KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: A report from the Children's Oncology Group
Amy K. Erbe*, Mitch B. Diccianni, Rajen Mody, Arlene Naranjo, Fan F. Zhang, Jen Birstler, Kyungmann Kim, Arika S. Feils, Jung Tung Hung, Wendy B. London, Barry L. Shulkin, Varsha Mathew, Marguerite T. Parisi, Sabah Servaes, Shahab Asgharzadeh, John M. Maris, Julie Park, Alice L. Yu, Paul M. Sondel, Rochelle Bagatell
Research output: Contribution to journal › Journal Article › peer-review
7Scopus
citations
Fingerprint
Dive into the research topics of 'KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: A report from the Children's Oncology Group'. Together they form a unique fingerprint.